8 completed, 6 unknown, 1 active not recruiting, 1 recruiting. 4 Not applicable, 4 Phase 1, 3 Phase 2, 3 Phase 3, 3 Phase 4.
Follow Haemophilus Influenzae Type B Infection: new trials by email Literature Review of Haemophilus Influenzae Type B Infection trials Research Report on Haemophilus Influenzae Type B Infection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Trial of the Adsorbed Acellular Pertussis (Tricomponent) DTaP-Haemophilus Influenzae Type b (Conjugate)-ACYW135 Group Meningococcal (Conjugate) Combined Vaccine Adsorbed Acellular Pertussis (3-Component) Diphtheria-Tetanus-Pertussis-Haemophilus influenzae type b (Conjugate)-Meningococcal Group ACYW135 (Conjugate) Combined Vaccine (DTcP-Hib-MCV4), DTcP-Hib-MCV4, Adsorbed Acellular Pertussis (3-Component) Diphtheria-Tetanus-Pertussis (DTcP) - Diphtheria, Tetanus and Acellular Pertussis, Epidemic Meningitis | Phase 1 | Recruiting | CanSino Biologics Inc. | 260 | 2025-12-19 | 2025-12-31 |
| Clinical Trial of Lyophilized Haemophilus Influenzae Type b Conjugate Vaccine Lyophilized Haemophilus Influenzae Type b Conjugate Vaccine, Haemophilus Influenzae Type b Conjugate Vaccine - Haemophilus Influenzae Type B Infection | Phase 1 | Active not recruiting | CanSino Biologics Inc. | 160 | 2024-11-15 | 2026-08-06 |
| Study to Evaluate the Immunogenicity of LR20062 Compared to Control When Administered Intramuscularly in Healthy Infants At 2, 4, 6 Months of Age LR20062, DTaP-HepB-IPV-Hib vaccine - Diphtheria, Tetanus | Phase 2 | Unknown | LG Chem | 336 | 2024-10-02 | 2024-10-01 |
| Safety and Immunogenicity of DTaP-IPV/Hib Pentavalent Vaccine in Chinese 2-month-old Infants Different immunization regiments with DTaP-IPV/Hib Pentavalent Vaccine - Pertussis, Diphtheria | Not applicable | Unknown | Jiangsu Province Centers for Disease Control and Prevention | 785 | 2024-09-05 | 2024-09-20 |
| A Study to Evaluate Safety and Immunogenicity of APV006 in Healthy Adults DTaP-HepB-IPV-Hib vaccine - Diphtheria, Tetanus | Phase 1 | Unknown | LG Chem | 42 | 2023-07-17 | 2023-07-19 |
| Immunogenicity of H. Influenzae Type b PRP-OMP Vaccines in American Indian and Alaska Native Children (the HibVax Study) Vaxelis, PedvaxHIB - Haemophilus Influenzae Type B Infection | Phase 4 | Completed | Johns Hopkins Bloomberg School of Public Health | 333 | 2022-01-27 | 2024-06-24 |
| Safety and Immunogenicity of Hexavalent Vaccine(DTwP-HepB-IPV-Hib) in Healthy Infants DTwP-HepB-Sabin IPV-Hib, Pentavalent vaccine and Salk IPV - Diphtheria, Tetanus | Phase 2 | Unknown | LG Chem | 336 | 2019-11-01 | 2019-09-06 |
| A Phase IV Study to Assess the Safety of EupentaTM Inj Eupenta Inj. - Hepatitis B, Diphtheria | Phase 4 | Unknown | LG Chem | 3000 | 2019-09-23 | 2019-08-14 |
| Study to Evaluate the Immunogenicity and Safety of LBVD(Hexavalent Vaccine), Given to Healthy Infants at Primary Series LBVD (Hexavalent vaccine), Pentavalent vaccine and Inactivated Polio vaccine (Sabin strains) - Diphtheria, Tetanus | Phase 2 / Phase 3 | Completed | LG Chem | 60 | 2018-07-18 | 2026-09-03 |
| Evaluation of an Infant Immunization Encouragement Program in Nigeria All Babies Are Equal Initiative (conditional cash transfer program) - Tuberculosis, Diphtheria | Not applicable | Completed | GiveWell | 5187 | 2018-07-01 | 2020-03-31 |
| Mobile Phone SMS Messages and Automated Calls in Improving Vaccine Coverage Among Children in Pakistan SMS messages and automated calls - Tuberculosis, Polio | Not applicable | Unknown | Aga Khan University | 3850 | 2018-01-01 | 2017-11-17 |
| A Study to Compare LBVD to Eupenta and Imovax Polio in Healthy Adults DTP-HepB-IPV-Hib vaccine, DTP-HepB-Hib vaccine & IPV - Diphtheria, Tetanus | Phase 1 | Completed | LG Chem | 42 | 2017-07-03 | 2019-08-29 |
| Evaluating a Caregiver SMS Reminder Intervention to Reduce Immunization Drop-out in Arua, Uganda SMS text reminders - Diphtheria, Tetanus | Not applicable | Completed | Centers for Disease Control and Prevention | 1962 | 2016-02-01 | 2019-11-26 |
| DTaP-IPV-Hep B-PRP~T Combined Vaccine Versus DTaP-IPV//PRP~T Combined Vaccine + Hep B Vaccine in Hep B Primed Infants DTaP-IPV-Hep B-PRP~T combined vaccine, DTaP-IPV//PRP~T and Hepatitis B vaccine - Diphtheria, Tetanus | Phase 3 | Completed | Sanofi Pasteur, a Sanofi Company | 310 | 2014-03-01 | 2017-04-26 |
| Safety of Haemophilus Influenza Type b Vaccine When Administered to Korean Children Haemophilus influenza type b conjugate vaccine - Haemophilus Influenzae Type B Infection | Phase 4 | Completed | Novartis Vaccines | 764 | 2011-08-01 | 2016-12-01 |
| Study of the DTaP-IPV-Hep B-PRP~T Combined Vaccine Following a Primary Series of DTacP IPV-HepB-PRP-T or Infanrix Hexa™ DTaP-IPV-Hep B-PRP~T vaccine (Batch 1), DTaP-IPV-Hep B-PRP~T vaccine (Batch 2), DTaP-IPV-Hep B-PRP~T vaccine (Batch 3) - Diphtheria, Tetanus | Phase 3 | Completed | Sanofi Pasteur, a Sanofi Company | 881 | 2008-03-01 | 2016-05-13 |
Haemophilus Infections (16) · Diphtheria (13) · Tetanus (13) · Whooping Cough (12) · Hepatitis B (11) · Poliomyelitis (11) · Measles (2) · Tuberculosis (2) · Meningitis, Meningococcal (1) · Pneumococcal Infections (1) · Pneumonia, Bacterial (1) · Rotavirus Infections (1) · Yellow Fever (1)
Bacterial Infections (16) · Bacterial Infections and Mycoses (16) · Gram-Negative Bacterial Infections (16) · Infections (16) · Pasteurellaceae Infections (16) · Actinomycetales Infections (13) · Clostridium Infections (13) · Corynebacterium Infections (13) · Gram-Positive Bacterial Infections (13) · Bordetella Infections (12) · Central Nervous System Diseases (12) · Central Nervous System Infections (12) · Nervous System Diseases (12) · Neuroinflammatory Diseases (12) · Respiratory Tract Diseases (12)
Vaccines, Combined (3) · Poliovirus Vaccine, Inactivated (2) · Euvax-B (1) · Haemophilus influenzae-type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine (1) · Hepatitis B Vaccines (1) · Methods (1) · Pentavac (1) · Saline Solution (1) · Sodium Chloride (1) · Vaxelis (1) · diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine (1)
LG Chem (6) · CanSino Biologics Inc. (2) · Sanofi Pasteur, a Sanofi Company (2) · Aga Khan University (1) · Centers for Disease Control and Prevention (1) · GiveWell (1) · Jiangsu Province Centers for Disease Control and Prevention (1) · Johns Hopkins Bloomberg School of Public Health (1) · Novartis Vaccines (1)
South Korea (4) · China (3) · Mexico (1) · Nigeria (1) · United States (1)
Abdul M Kazi, MBBS,MPH (1) · Alison Connor, PhD (1) · Daniel C Ehlman, MPH (1) · Edison Alberto, MD (1) · Hongying Li (1) · Josefina Carlos, MD (1) · Laura Hammitt, MD (1) · Nam Joong Kim (1) · WJ Kim (1) · Yanxia Wang (1)